glp-1 drugs wegovy weight loss may be misused by patients with eating disorders: Study A GLP-1 Pill May Help

Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone that potentiates glucose-induced insulin secretion in the postprandial state

Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability

The two incretin peptides that enable this effect are the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide 1 (GLP-1), which ...

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users

Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor agonists are a ...

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.